| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 3.48e-06 | 5 | 142 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 4.04e-05 | 130 | 142 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | cadherin binding | 1.60e-04 | 339 | 142 | 10 | GO:0045296 | |
| GeneOntologyMolecularFunction | galactose 3-O-sulfotransferase activity | 2.98e-04 | 4 | 142 | 2 | GO:0050694 | |
| GeneOntologyMolecularFunction | galactosylceramide sulfotransferase activity | 2.98e-04 | 4 | 142 | 2 | GO:0001733 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 4.41e-07 | 99 | 143 | 8 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 4.77e-07 | 100 | 143 | 8 | GO:0045103 | |
| GeneOntologyBiologicalProcess | developmental growth | SEMA3F BNC2 DRD2 ATN1 DBNL DVL1 MAP7 SKI SPTBN4 HOXA11 RNF6 NRK SCAPER NKX2-5 MACF1 AFDN PLEC LZTS2 MYMX | 1.79e-05 | 911 | 143 | 19 | GO:0048589 |
| GeneOntologyBiologicalProcess | mRNA processing | SRSF4 AKAP17A CDK12 CWC15 ZC3H13 CDK11A SCAF4 FRA10AC1 RBM25 TCERG1 ARVCF SLTM SCAF11 CLP1 | 3.03e-05 | 551 | 143 | 14 | GO:0006397 |
| GeneOntologyCellularComponent | nuclear body | NOLC1 AMER1 SRSF4 AKAP17A CDK12 CWC15 ZC3H13 SKI PNISR TOE1 HEXIM2 SPTBN4 RBM25 RNF6 TCERG1 SCAPER SLTM NHS AFDN SCAF11 | 2.54e-06 | 903 | 140 | 20 | GO:0016604 |
| GeneOntologyCellularComponent | supramolecular fiber | NES DBNL KIF16B DVL1 STYXL2 EVPL FHOD3 LMNB2 MAP7 PPL BFSP1 SPTBN4 TFPT INA MYH14 CFAP45 MACF1 JAKMIP1 PLEC LZTS2 TNNT1 NUDC | 1.20e-05 | 1179 | 140 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | NES DBNL KIF16B DVL1 STYXL2 EVPL FHOD3 LMNB2 MAP7 PPL BFSP1 SPTBN4 TFPT INA MYH14 CFAP45 MACF1 JAKMIP1 PLEC LZTS2 TNNT1 NUDC | 1.33e-05 | 1187 | 140 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | NES DBNL KIF16B DVL1 EVPL LMNB2 MAP7 PPL BFSP1 SPTBN4 TFPT INA CFAP45 MACF1 JAKMIP1 PLEC LZTS2 NUDC | 3.25e-05 | 899 | 140 | 18 | GO:0099513 |
| GeneOntologyCellularComponent | nuclear speck | SRSF4 AKAP17A CDK12 CWC15 ZC3H13 PNISR TOE1 HEXIM2 RBM25 TCERG1 SCAPER AFDN | 3.42e-05 | 431 | 140 | 12 | GO:0016607 |
| GeneOntologyCellularComponent | intermediate filament | 1.49e-04 | 227 | 140 | 8 | GO:0005882 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 4.04e-04 | 263 | 140 | 8 | GO:0045111 | |
| GeneOntologyCellularComponent | manchette | 8.52e-04 | 28 | 140 | 3 | GO:0002177 | |
| Domain | Plectin_repeat | 1.10e-07 | 7 | 142 | 4 | IPR001101 | |
| Domain | Plectin | 1.10e-07 | 7 | 142 | 4 | PF00681 | |
| Domain | PLEC | 1.10e-07 | 7 | 142 | 4 | SM00250 | |
| Domain | MAP7_fam | 1.71e-06 | 4 | 142 | 3 | IPR008604 | |
| Domain | MAP7 | 1.71e-06 | 4 | 142 | 3 | PF05672 | |
| Domain | Spectrin_repeat | 2.43e-06 | 29 | 142 | 5 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 4.04e-06 | 32 | 142 | 5 | IPR018159 | |
| Domain | SPEC | 4.04e-06 | 32 | 142 | 5 | SM00150 | |
| Domain | - | 8.46e-06 | 6 | 142 | 3 | 3.90.1290.10 | |
| Domain | DVL-1 | 5.74e-05 | 2 | 142 | 2 | IPR008340 | |
| Domain | FHA_dom | 1.56e-04 | 36 | 142 | 4 | IPR000253 | |
| Domain | - | 1.56e-04 | 36 | 142 | 4 | 2.60.200.20 | |
| Domain | Dishevelled_fam | 3.41e-04 | 4 | 142 | 2 | IPR008339 | |
| Domain | Dishevelled | 3.41e-04 | 4 | 142 | 2 | PF02377 | |
| Domain | Gal-3-0_sulfotransfrase | 3.41e-04 | 4 | 142 | 2 | IPR009729 | |
| Domain | Dishevelled_protein_dom | 3.41e-04 | 4 | 142 | 2 | IPR003351 | |
| Domain | Gal-3-0_sulfotr | 3.41e-04 | 4 | 142 | 2 | PF06990 | |
| Domain | SMAD_FHA_domain | 6.53e-04 | 52 | 142 | 4 | IPR008984 | |
| Domain | Actinin_actin-bd_CS | 6.82e-04 | 23 | 142 | 3 | IPR001589 | |
| Domain | ACTININ_2 | 6.82e-04 | 23 | 142 | 3 | PS00020 | |
| Domain | ACTININ_1 | 6.82e-04 | 23 | 142 | 3 | PS00019 | |
| Domain | DIL | 8.44e-04 | 6 | 142 | 2 | PF01843 | |
| Domain | Dilute_dom | 8.44e-04 | 6 | 142 | 2 | IPR002710 | |
| Domain | SPOC_C | 8.44e-04 | 6 | 142 | 2 | IPR012921 | |
| Domain | DILUTE | 8.44e-04 | 6 | 142 | 2 | PS51126 | |
| Domain | DIL | 8.44e-04 | 6 | 142 | 2 | SM01132 | |
| Domain | SPOC | 8.44e-04 | 6 | 142 | 2 | PF07744 | |
| Domain | DIX | 1.18e-03 | 7 | 142 | 2 | PF00778 | |
| Domain | DIX | 1.18e-03 | 7 | 142 | 2 | IPR001158 | |
| Domain | DIX | 1.18e-03 | 7 | 142 | 2 | PS50841 | |
| Domain | DAX | 1.18e-03 | 7 | 142 | 2 | SM00021 | |
| Domain | FHA_DOMAIN | 1.65e-03 | 31 | 142 | 3 | PS50006 | |
| Domain | FHA | 1.65e-03 | 31 | 142 | 3 | PF00498 | |
| Domain | Filament | 2.10e-03 | 71 | 142 | 4 | SM01391 | |
| Domain | IF | 2.21e-03 | 72 | 142 | 4 | PS00226 | |
| Domain | Filament | 2.32e-03 | 73 | 142 | 4 | PF00038 | |
| Domain | - | 2.66e-03 | 244 | 142 | 7 | 3.30.70.330 | |
| Domain | IF | 2.69e-03 | 76 | 142 | 4 | IPR001664 | |
| Domain | Ubiquitin-rel_dom | 2.85e-03 | 184 | 142 | 6 | IPR029071 | |
| Domain | SH3_9 | 2.96e-03 | 78 | 142 | 4 | PF14604 | |
| Domain | Nucleotide-bd_a/b_plait | 3.62e-03 | 258 | 142 | 7 | IPR012677 | |
| Domain | SH3_2 | 4.20e-03 | 86 | 142 | 4 | IPR011511 | |
| Domain | SH3_2 | 4.20e-03 | 86 | 142 | 4 | PF07653 | |
| Domain | PDZ | 4.48e-03 | 141 | 142 | 5 | PF00595 | |
| Domain | PDZ | 5.49e-03 | 148 | 142 | 5 | SM00228 | |
| Domain | PDZ | 5.97e-03 | 151 | 142 | 5 | PS50106 | |
| Domain | PDZ | 6.14e-03 | 152 | 142 | 5 | IPR001478 | |
| Domain | SH3 | 6.21e-03 | 216 | 142 | 6 | PS50002 | |
| Domain | SH3_domain | 6.78e-03 | 220 | 142 | 6 | IPR001452 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 ATN1 AKAP8 ARGLU1 CDK12 ZC3H13 CDK11A DIDO1 PNISR PPL HEXIM2 SCAF4 STK10 RBM25 UTP18 PWWP2B KANSL1 GTF3C1 CCAR1 TJP2 AFDN SCAF11 PLEC SPEN PRRC2A | 4.02e-15 | 774 | 149 | 25 | 15302935 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | NOLC1 ANKRD35 AMER1 CDK12 NOP53 ZC3H13 DIDO1 MAP7 MAST2 PNISR SPTBN4 PHLDB1 MAP7D1 SLTM TJP2 MACF1 SPEN PRRC2A | 2.62e-14 | 361 | 149 | 18 | 26167880 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 SRSF4 AKAP8 ARGLU1 CWC15 ZC3H13 DIDO1 LMNB2 MAP7 SKI PNISR SCAF4 FOSL1 NCOA5 HOXA11 TFPT MAP7D1 RBM25 UTP18 KANSL1 GTF3C1 TCERG1 NFKBIL1 SLTM CCAR1 NOL7 SCAF11 SPEN TET3 CBX8 | 3.45e-14 | 1294 | 149 | 30 | 30804502 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOLC1 NES SRSF4 AKAP8 AKAP17A ARGLU1 CDK12 ZC3H13 DIDO1 LMNB2 PNISR TOE1 SCAF4 NCOA5 RBM25 INA GTF3C1 TCERG1 CFAP45 SLTM CCAR1 MACF1 GNA12 PLEC CLP1 SPEN CBX8 | 1.40e-13 | 1082 | 149 | 27 | 38697112 |
| Pubmed | NOLC1 NES SRSF4 NOP53 ZC3H13 DIDO1 LMNB2 RBM25 UTP18 INA GTF3C1 MYH14 SLTM CCAR1 TJP2 MACF1 AFDN SCAF11 PLEC SPEN PRRC2A | 8.33e-13 | 653 | 149 | 21 | 22586326 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NOLC1 AKAP8 ARGLU1 NOP53 CWC15 ZC3H13 LAMB3 DIDO1 EVPL LMNB2 MAP7 TOE1 PPL NCOA5 MAP7D1 RBM25 UTP18 GTF3C1 TCERG1 SLTM TJP2 SCAF11 PLEC LZTS2 SPEN NUDC CBX8 | 4.58e-12 | 1257 | 149 | 27 | 36526897 |
| Pubmed | NOLC1 SRSF4 AKAP17A ARGLU1 CDK12 ZC3H13 PNISR TOE1 SCAF4 NCOA5 MYH14 CCAR1 SCAF11 SPEN | 4.95e-12 | 251 | 149 | 14 | 31076518 | |
| Pubmed | NOLC1 AKAP8 CDK12 ZC3H13 DBNL DIDO1 MAP7 ANKZF1 STK10 RBSN RBM25 UTP18 GTF3C1 TJP2 NHS AFDN SPEN PRRC2A | 6.96e-12 | 503 | 149 | 18 | 16964243 | |
| Pubmed | AKAP8 AKAP17A ARGLU1 CDK12 NOP53 DBNL CDK11A DIDO1 MAP7 ANKZF1 PNISR TOE1 SCAF4 CRACD TFPT MAP7D1 TCERG1 CCAR1 MACF1 AFDN NOL7 SCAF11 LZTS2 CLP1 SPEN PRRC2A HOMER3 CBX8 CKMT1A | 8.11e-12 | 1497 | 149 | 29 | 31527615 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 SRSF4 ARGLU1 CDK12 NOP53 CWC15 ZC3H13 CDK11A DIDO1 SCAF4 ZNF711 RBM25 TCERG1 SLTM CCAR1 NKX2-5 AFDN NOL7 SCAF11 SPEN PRRC2A CBX8 CKMT1A | 2.18e-11 | 954 | 149 | 23 | 36373674 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | NOLC1 SRSF4 AKAP8 AKAP17A NOP53 ZC3H13 FBRSL1 DIDO1 PNISR SCAF4 NCOA5 RBM25 UTP18 TCERG1 SLTM CCAR1 MACF1 SCAF11 SPEN PRRC2A | 3.08e-10 | 807 | 149 | 20 | 22681889 |
| Pubmed | NOLC1 CCDC8 ATN1 AKAP8 NOP53 FBRSL1 CDK11A DIDO1 MAP7 SKI HEXIM2 SCAF4 TFPT MAP7D1 RBM25 KANSL1 GTF3C1 TCERG1 MYH14 CCAR1 NKX2-5 SCAF11 CLP1 SPEN NUDC PRRC2A | 4.35e-10 | 1429 | 149 | 26 | 35140242 | |
| Pubmed | COL6A2 ATN1 CDK12 UBE3B FBRSL1 LAMB3 DIDO1 GMIP MAST2 ANKZF1 MAP3K6 MAP7D1 GTF3C1 TCERG1 ARVCF SLTM CCAR1 AFDN | 4.44e-10 | 650 | 149 | 18 | 38777146 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 NES CCDC8 AMER1 AKAP8 DBNL MAP7 MAST2 MAP3K6 RBSN PHLDB1 MAP7D1 INA TCERG1 PIK3C2B TJP2 NHS MACF1 AFDN PLEC | 9.42e-10 | 861 | 149 | 20 | 36931259 |
| Pubmed | NES AKAP8 TRAF3IP1 ARGLU1 ARHGEF18 DIDO1 LMNB2 GRM4 CCDC177 SPTBN4 MAP7D1 INA ARVCF CCAR1 MACF1 AFDN JAKMIP1 BSN PRRC2A HOMER3 PHACTR1 | 1.07e-09 | 963 | 149 | 21 | 28671696 | |
| Pubmed | NOLC1 AMER1 DBNL LMNB2 SKI PNISR PPL SPTBN4 FRA10AC1 MAP7D1 UTP18 INA GTF3C1 MYH14 CFAP45 CCAR1 MAP7D2 CC2D2A MACF1 GNA12 JAKMIP1 PLEC BSN TNNT1 SPEN | 2.62e-09 | 1442 | 149 | 25 | 35575683 | |
| Pubmed | NOLC1 SRSF4 ARGLU1 CDK12 NOP53 CWC15 ZC3H13 LMNB2 NCOA5 CRACD PHLDB1 RBM25 UTP18 TCERG1 SLTM NOL7 SPEN PRRC2A | 2.82e-09 | 731 | 149 | 18 | 29298432 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NOLC1 NES CCDC8 AKAP8 ARGLU1 LMNB2 SCAF4 NCOA5 PHLDB1 RBM25 INA GTF3C1 MYH14 SLTM TJP2 MACF1 AFDN NOL7 PLEC SPEN NUDC | 3.15e-09 | 1024 | 149 | 21 | 24711643 |
| Pubmed | NOLC1 ATN1 AKAP8 AKAP17A ARGLU1 FBRSL1 CRACR2B MAP7 SKI MAST2 ZNF711 TFPT MAP7D1 RBM25 TCHH PWWP2B NFKBIL1 SCAPER MACF1 LZTS2 UNC80 | 1.40e-08 | 1116 | 149 | 21 | 31753913 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NOLC1 CCDC8 AKAP8 AKAP17A CDK12 NOP53 DIDO1 NCOA5 UTP18 GTF3C1 TCERG1 SCAPER MACF1 NOL7 SCAF11 PRRC2A CBX8 | 3.18e-08 | 759 | 149 | 17 | 35915203 |
| Pubmed | NES ARGLU1 DBNL GJC2 MAP7 CCDC177 SPTBN4 CRACD PHLDB1 MAP7D1 INA ARVCF MYH14 SCAPER TJP2 MAP7D2 MACF1 AFDN PLEC BSN PRRC2A HOMER3 CKMT1A | 4.89e-08 | 1431 | 149 | 23 | 37142655 | |
| Pubmed | AKAP8 AKAP17A CDK12 CWC15 DIDO1 ANKZF1 TOE1 HEXIM2 SCAF4 MAP7D1 RBM25 TCERG1 MYH14 CCAR1 TJP2 NOL7 SCAF11 PLEC LZTS2 GNL1 PRRC2A CBX8 | 1.02e-07 | 1371 | 149 | 22 | 36244648 | |
| Pubmed | SRSF4 AKAP8 TOE1 NCOA5 RBM25 GTF3C1 SLTM CCAR1 SCAF11 PRRC2A | 1.12e-07 | 244 | 149 | 10 | 29884807 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | NOLC1 AMER1 EID2 DVL1 FBRSL1 GMIP ANKZF1 PNISR ZBED3 HEXIM2 STK10 FRA10AC1 PHLDB1 TFPT UTP18 PIK3C2B TJP2 LZTS2 ATG16L2 | 1.12e-07 | 1038 | 149 | 19 | 26673895 |
| Pubmed | CDK12 DBNL DVL1 DIDO1 SCAF4 RBM25 GTF3C1 TCERG1 TJP2 AFDN LZTS2 SPEN NUDC PRRC2A | 1.17e-07 | 549 | 149 | 14 | 38280479 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NOLC1 NOP53 DBNL MISP3 LMNB2 MAST2 TOE1 NCOA5 RBM25 UTP18 GTF3C1 TCERG1 MYH14 SLTM CCAR1 CC2D2A AFDN NOL7 BSN SPEN NUDC CKMT1A | 1.97e-07 | 1425 | 149 | 22 | 30948266 |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | SRSF4 NOP53 LAMB3 ARHGEF18 DIDO1 LMNB2 MAP7D1 UTP18 GTF3C1 MYH14 SCAF11 SPEN | 2.28e-07 | 410 | 149 | 12 | 26949251 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA3F CDK12 POLG UBE3B DVL1 FBRSL1 LAMB3 LMNB2 MAST2 ZBED3 STK10 PHLDB1 PWWP2B KANSL1 ARVCF PIK3C2B GNA12 PLEC SPEN | 2.91e-07 | 1105 | 149 | 19 | 35748872 |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 3.07e-07 | 4 | 149 | 3 | 19091768 | |
| Pubmed | NES SRSF4 CWC15 DBNL ARHGEF18 LMNB2 GMIP ARHGAP22 MAP7D1 RBM25 INA TCERG1 CCAR1 TJP2 NOL7 PLEC PRRC2A | 4.53e-07 | 916 | 149 | 17 | 32203420 | |
| Pubmed | SRSF4 AKAP8 ARGLU1 CDK12 ZC3H13 TOE1 HEXIM2 SCAF4 MAP7D1 RBM25 GTF3C1 SLTM CCAR1 PRRC2A CKMT1A | 4.75e-07 | 713 | 149 | 15 | 29802200 | |
| Pubmed | 4.85e-07 | 360 | 149 | 11 | 33111431 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | NOP53 DBNL CDK11A CBFB GTF2E1 MAP7D1 GTF3C1 SLTM SCAF11 PLEC PRRC2A | 6.35e-07 | 370 | 149 | 11 | 22922362 |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 7.66e-07 | 5 | 149 | 3 | 17855024 | |
| Pubmed | SRSF4 AKAP8 NOP53 ZC3H13 EVPL TOE1 NCOA5 RBM25 GTF3C1 TCERG1 MYH14 SLTM CCAR1 TJP2 SCAF11 PRRC2A | 8.01e-07 | 847 | 149 | 16 | 35850772 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | ANKRD35 ZNF821 ATN1 DBNL SLC13A3 SPTBN4 ARHGAP22 PHLDB1 INA JAKMIP1 LZTS2 ADAMTSL4 HOMER3 | 9.69e-07 | 560 | 149 | 13 | 21653829 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NOLC1 NES AKAP8 NOP53 DIDO1 LMNB2 TOE1 NCOA5 RBM25 UTP18 GTF3C1 TCERG1 SLTM CCAR1 NOL7 SCAF11 PLEC | 1.29e-06 | 989 | 149 | 17 | 36424410 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CWC15 CDK11A TOE1 SCAF4 PHLDB1 MAP7D1 GTF3C1 PIK3C2B CCAR1 TJP2 NUDC CKMT1A | 1.72e-06 | 497 | 149 | 12 | 36774506 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | MAGEB1 CCDC8 SRSF4 AKAP8 ARGLU1 CDK12 CDK11A DIDO1 SKI GTF2E1 RBM25 TJP2 LZTS2 HOMER3 | 1.94e-06 | 695 | 149 | 14 | 23602568 |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | CDK12 CWC15 ZC3H13 DBNL GMIP PNISR TOE1 UTP18 TCERG1 SLTM CCAR1 PLEC PRRC2A ATG16L2 | 2.14e-06 | 701 | 149 | 14 | 30196744 |
| Pubmed | ZNF821 CFAP91 TRAF3IP1 AKAP17A ARGLU1 POLG CBFB PNISR RXRG BFSP1 SPTBN4 TCERG1 MYH14 CCAR1 MACF1 AFDN JAKMIP1 PLEC PRRC2A | 2.72e-06 | 1285 | 149 | 19 | 35914814 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | COL6A2 ZNF821 MAGEB1 KIF16B MAST2 ANKZF1 CRACD SLTM NHS PLEC | 4.10e-06 | 363 | 149 | 10 | 14691545 |
| Pubmed | 5.23e-06 | 220 | 149 | 8 | 24550385 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ARGLU1 DBNL EVPL PPL ARVCF TJP2 NHS MACF1 AFDN PLEC LZTS2 NUDC | 6.35e-06 | 565 | 149 | 12 | 25468996 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 7.47e-06 | 231 | 149 | 8 | 16452087 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | NOLC1 SRSF4 AKAP8 ARGLU1 CDK12 CWC15 MAP7 KANSL1 MACF1 PLEC CLP1 NUDC | 8.55e-06 | 582 | 149 | 12 | 20467437 |
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 9.22e-06 | 170 | 149 | 7 | 16159877 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | CCDC8 ATN1 AKAP8 NOP53 FBRSL1 DIDO1 LMNB2 TFPT KANSL1 NUDC CBX8 | 1.03e-05 | 495 | 149 | 11 | 27705803 |
| Pubmed | 1.65e-05 | 12 | 149 | 3 | 23884928 | ||
| Pubmed | 1.71e-05 | 187 | 149 | 7 | 26460568 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 11062259 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 15033990 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 8644734 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 17662978 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 18820940 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 11323440 | ||
| Pubmed | Interaction of periplakin and envoplakin with intermediate filaments. | 1.82e-05 | 2 | 149 | 2 | 12432088 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 30784582 | ||
| Pubmed | Map7/7D1 and Dvl form a feedback loop that facilitates microtubule remodeling and Wnt5a signaling. | 1.82e-05 | 2 | 149 | 2 | 29880710 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NOLC1 NES DBNL LMNB2 TOE1 PHLDB1 MAP7D1 UTP18 KANSL1 GTF3C1 TCERG1 ARVCF MYH14 SLTM CCAR1 MACF1 AFDN PLEC | 2.11e-05 | 1353 | 149 | 18 | 29467282 |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 2.15e-05 | 130 | 149 | 6 | 35545047 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 2.24e-05 | 269 | 149 | 8 | 29511261 | |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 2.39e-05 | 197 | 149 | 7 | 22365833 | |
| Pubmed | SRSF4 AKAP8 CDK12 NOP53 MAP7 TOE1 SCAF4 RBM25 UTP18 SLTM BSN GNL1 | 2.66e-05 | 653 | 149 | 12 | 33742100 | |
| Pubmed | NOLC1 ANKRD35 AMER1 SRSF4 ATN1 ARGLU1 DVL1 CBFB HEXIM2 RBM25 RNF6 ARVCF MYH14 NHS LZTS2 NUDC PRRC2A | 2.67e-05 | 1247 | 149 | 17 | 27684187 | |
| Pubmed | Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library. | 2.71e-05 | 14 | 149 | 3 | 17662146 | |
| Pubmed | 2.90e-05 | 203 | 149 | 7 | 35012549 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.22e-05 | 283 | 149 | 8 | 30585729 | |
| Pubmed | NOLC1 ARGLU1 CDK12 DIDO1 LMNB2 CBFB FOSL1 NCOA5 GTF2E1 RBM25 GTF3C1 TCERG1 SLTM CCAR1 PLEC | 3.26e-05 | 1014 | 149 | 15 | 32416067 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | SRSF4 AKAP8 CDK12 SCAF4 RBM25 GTF3C1 MYH14 CCAR1 NOL7 SCAF11 NUDC CBX8 | 3.41e-05 | 670 | 149 | 12 | 22990118 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | NES SRSF4 AKAP8 CDK12 DBNL MAP7 SCAF4 MAP7D1 INA GTF3C1 TCERG1 MACF1 AFDN PLEC NUDC PRRC2A | 3.63e-05 | 1149 | 149 | 16 | 35446349 |
| Pubmed | 3.72e-05 | 469 | 149 | 10 | 27634302 | ||
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | ANKRD35 SRSF4 CDK11A LAMB3 GJC2 SKI MAST2 RXRG TOE1 YOD1 PIK3C2B MACF1 SPEN NUDC ADAMTSL4 | 3.94e-05 | 1031 | 149 | 15 | 16710414 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | NOLC1 CDK12 FBRSL1 CDK11A MAP3K6 HEXIM2 STK10 GTF3C1 NRK SCAPER PLEC LZTS2 GNL1 ATG16L2 | 3.96e-05 | 910 | 149 | 14 | 36736316 |
| Pubmed | 4.18e-05 | 215 | 149 | 7 | 35973513 | ||
| Pubmed | 5.01e-05 | 17 | 149 | 3 | 32986815 | ||
| Pubmed | Two distinct phosphorylation events govern the function of muscle FHOD3. | 5.45e-05 | 3 | 149 | 2 | 23052206 | |
| Pubmed | Epidermal barrier defects link atopic dermatitis with altered skin cancer susceptibility. | 5.45e-05 | 3 | 149 | 2 | 24843010 | |
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 14701868 | ||
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 9412476 | ||
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 11854008 | ||
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 26763429 | ||
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 11333265 | ||
| Pubmed | MAP7 family proteins regulate kinesin-1 recruitment and activation. | 5.45e-05 | 3 | 149 | 2 | 30770434 | |
| Pubmed | 5.64e-05 | 396 | 149 | 9 | 26687479 | ||
| Pubmed | CCDC8 ARGLU1 NOP53 FHOD3 MAP7D1 CFAP45 SLTM MACF1 PLEC PRRC2A | 5.94e-05 | 496 | 149 | 10 | 31343991 | |
| Pubmed | 6.00e-05 | 18 | 149 | 3 | 25794677 | ||
| Pubmed | SRSF4 CDK11A LAMB3 DIDO1 ANKZF1 GTF3C1 MYH14 MACF1 SCAF11 PLEC CBX8 | 6.03e-05 | 601 | 149 | 11 | 33658012 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NOLC1 AKAP17A ARGLU1 NOP53 CDK11A MAP7 TOE1 RBM25 UTP18 TCERG1 MYH14 SLTM NOL7 PLEC | 6.21e-05 | 949 | 149 | 14 | 36574265 |
| Pubmed | 6.65e-05 | 159 | 149 | 6 | 34537242 | ||
| Pubmed | NOLC1 ZNF821 AMER1 ZC3H13 POLG DBNL ARHGEF18 DIDO1 DDI2 EXOC3L4 SLTM TJP2 MACF1 PLEC PHACTR1 | 6.91e-05 | 1084 | 149 | 15 | 11544199 | |
| Pubmed | NOLC1 CDK12 CWC15 DBNL PNISR SCAF4 CRACD GTF2E1 RBM25 TCERG1 | 7.00e-05 | 506 | 149 | 10 | 30890647 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | AMER1 POLG TMEM63B FBRSL1 ARHGEF18 SKI HEXIM2 SPTBN4 STK10 PHLDB1 PWWP2B GTF3C1 MYH14 CCAR1 MACF1 SCAF11 LZTS2 TET3 | 7.27e-05 | 1489 | 149 | 18 | 28611215 |
| Pubmed | 8.33e-05 | 20 | 149 | 3 | 32079660 | ||
| Pubmed | 8.82e-05 | 104 | 149 | 5 | 31365120 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 8.83e-05 | 420 | 149 | 9 | 28065597 | |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 9.24e-05 | 329 | 149 | 8 | 34316702 | |
| Pubmed | 9.66e-05 | 425 | 149 | 9 | 24999758 | ||
| Pubmed | 1.05e-04 | 335 | 149 | 8 | 15741177 | ||
| Pubmed | 1.07e-04 | 57 | 149 | 4 | 29089450 | ||
| Interaction | SRPK2 interactions | NOLC1 ANKRD35 MAGEB1 AMER1 SRSF4 AKAP17A ARGLU1 CDK12 NOP53 ZC3H13 DIDO1 MAP7 MAST2 PNISR TOE1 SCAF4 GTF2E1 PHLDB1 MAP7D1 SLTM CCAR1 TJP2 MACF1 SCAF11 SPEN PRRC2A HOMER3 | 1.41e-12 | 717 | 145 | 27 | int:SRPK2 |
| Interaction | PSENEN interactions | ARGLU1 ZC3H13 DIDO1 MAP7 SCAF4 FRA10AC1 UTP18 SLTM TJP2 SCAF11 PRRC2A | 1.44e-11 | 81 | 145 | 11 | int:PSENEN |
| Interaction | IFI27L1 interactions | ARGLU1 CDK12 ZC3H13 DIDO1 NCOA5 RBM25 SLTM TJP2 SCAF11 PRRC2A | 3.47e-11 | 65 | 145 | 10 | int:IFI27L1 |
| Interaction | LINC02910 interactions | CDK12 ZC3H13 LENG1 DIDO1 MAP7 NCOA5 UTP18 SLTM TJP2 SCAF11 PRRC2A | 8.49e-11 | 95 | 145 | 11 | int:LINC02910 |
| Interaction | GAGE5 interactions | 1.14e-10 | 52 | 145 | 9 | int:GAGE5 | |
| Interaction | IFI6 interactions | 1.62e-10 | 54 | 145 | 9 | int:IFI6 | |
| Interaction | UQCR11 interactions | 3.99e-09 | 53 | 145 | 8 | int:UQCR11 | |
| Interaction | EZH1 interactions | 2.11e-08 | 92 | 145 | 9 | int:EZH1 | |
| Interaction | MECP2 interactions | NOLC1 NES SRSF4 AKAP8 AKAP17A ARGLU1 CDK12 ZC3H13 DIDO1 LMNB2 SKI PNISR TOE1 SCAF4 NCOA5 ARHGAP22 RBM25 INA GTF3C1 TCERG1 CFAP45 SLTM CCAR1 MACF1 GNA12 PLEC CLP1 SPEN CBX8 | 3.30e-08 | 1287 | 145 | 29 | int:MECP2 |
| Interaction | ANKRD50 interactions | 8.60e-08 | 108 | 145 | 9 | int:ANKRD50 | |
| Interaction | SIRT7 interactions | NOLC1 NES SRSF4 NOP53 ZC3H13 DIDO1 LMNB2 RBM25 UTP18 INA GTF3C1 MYH14 SLTM CCAR1 TJP2 MACF1 AFDN SCAF11 PLEC SPEN PRRC2A | 8.67e-08 | 744 | 145 | 21 | int:SIRT7 |
| Interaction | DHX8 interactions | SRSF4 AKAP17A CDK12 CWC15 ZC3H13 CDK11A PNISR RBM25 KANSL1 TCERG1 SLTM SCAF11 SPEN | 1.99e-07 | 292 | 145 | 13 | int:DHX8 |
| Interaction | TMSB4Y interactions | 3.35e-07 | 39 | 145 | 6 | int:TMSB4Y | |
| Interaction | ANAPC15 interactions | 3.71e-07 | 128 | 145 | 9 | int:ANAPC15 | |
| Interaction | DDX23 interactions | NOLC1 SRSF4 AKAP17A ARGLU1 CDK12 NOP53 CWC15 ZC3H13 CDK11A PNISR GTF2E1 RBM25 TCERG1 SLTM TJP2 SCAF11 | 3.86e-07 | 480 | 145 | 16 | int:DDX23 |
| Interaction | SMC5 interactions | NOLC1 SRSF4 ARGLU1 CDK12 NOP53 CWC15 ZC3H13 CDK11A DIDO1 SCAF4 ZNF711 RBM25 TCERG1 SLTM CCAR1 NKX2-5 AFDN NOL7 SCAF11 SPEN PRRC2A CBX8 CKMT1A | 7.55e-07 | 1000 | 145 | 23 | int:SMC5 |
| Interaction | SNRNP40 interactions | ATN1 AKAP8 AKAP17A CDK12 NOP53 CWC15 ZC3H13 DVL1 PNISR TOE1 SCAF4 NCOA5 RBM25 TCERG1 CCAR1 SCAF11 SPEN CBX8 | 7.75e-07 | 637 | 145 | 18 | int:SNRNP40 |
| Interaction | YWHAH interactions | NOLC1 NES CCDC8 AMER1 AKAP8 ZC3H13 DBNL MAP7 MAST2 MAP3K6 RBSN PHLDB1 MAP7D1 INA TCERG1 PIK3C2B TJP2 CC2D2A NHS MACF1 AFDN JAKMIP1 PLEC HOMER3 | 1.11e-06 | 1102 | 145 | 24 | int:YWHAH |
| Interaction | BMI1 interactions | SRSF4 AKAP8 ARGLU1 ZC3H13 DIDO1 EVPL LMNB2 CBFB NCOA5 TFPT SLC11A1 GTF3C1 SLTM SCAF11 PLEC SPEN PRRC2A CBX8 | 1.26e-06 | 659 | 145 | 18 | int:BMI1 |
| Interaction | ZC3H18 interactions | NOLC1 SRSF4 AKAP17A ARGLU1 CDK12 NOP53 CWC15 ZC3H13 CDK11A LMNB2 NCOA5 CRACD PHLDB1 RBM25 UTP18 TCERG1 NFKBIL1 SLTM NOL7 SPEN PRRC2A | 1.28e-06 | 877 | 145 | 21 | int:ZC3H18 |
| Interaction | SAA1 interactions | 2.43e-06 | 54 | 145 | 6 | int:SAA1 | |
| Interaction | CFAP141 interactions | 2.71e-06 | 55 | 145 | 6 | int:CFAP141 | |
| Interaction | HERC2 interactions | CCDC8 SRSF4 AKAP17A ARGLU1 CDK12 DBNL FHOD3 LMNB2 MAP7 PPL MAP7D1 RBM25 MAP7D2 MACF1 PLEC | 3.59e-06 | 503 | 145 | 15 | int:HERC2 |
| Interaction | SNRPC interactions | SRSF4 AKAP8 ARGLU1 CDK12 CWC15 DIDO1 TOE1 SCAF4 NCOA5 RBM25 TCERG1 MACF1 SCAF11 SPEN | 3.68e-06 | 440 | 145 | 14 | int:SNRPC |
| Interaction | H2AJ interactions | 3.85e-06 | 127 | 145 | 8 | int:H2AJ | |
| Interaction | GAGE2E interactions | 5.67e-06 | 36 | 145 | 5 | int:GAGE2E | |
| Interaction | RAD18 interactions | NOLC1 SRSF4 AKAP17A ARGLU1 CDK12 ZC3H13 PNISR TOE1 SCAF4 NCOA5 MYH14 CCAR1 SCAF11 SPEN | 5.68e-06 | 457 | 145 | 14 | int:RAD18 |
| Interaction | YWHAG interactions | NOLC1 CCDC8 AMER1 AKAP8 AKAP17A CDK12 ZC3H13 DBNL MAP7 MAST2 MAP3K6 CRACD PHLDB1 MAP7D1 INA TCERG1 PIK3C2B TJP2 NHS MACF1 AFDN SCAF11 JAKMIP1 LZTS2 | 9.39e-06 | 1248 | 145 | 24 | int:YWHAG |
| Interaction | CIT interactions | NOLC1 ANKRD35 NES ARGLU1 NOP53 CWC15 ZC3H13 CDK11A DIDO1 LMNB2 MAP7 TOE1 BFSP1 NCOA5 SPTBN4 RBM25 UTP18 INA TCERG1 MYH14 TJP2 MACF1 NOL7 SCAF11 PLEC PRRC2A | 1.31e-05 | 1450 | 145 | 26 | int:CIT |
| Interaction | MEN1 interactions | NOLC1 SRSF4 ATN1 AKAP8 NOP53 ZC3H13 DIDO1 TOE1 FOSL1 RBM25 KANSL1 GTF3C1 TCERG1 MYH14 SLTM TJP2 AFDN SCAF11 SPEN PRRC2A CBX8 | 1.51e-05 | 1029 | 145 | 21 | int:MEN1 |
| Interaction | MYCN interactions | NOLC1 SRSF4 AKAP8 ARGLU1 CDK12 NOP53 CWC15 ZC3H13 CDK11A DIDO1 MAP7 TOE1 PPL MAP7D1 UTP18 INA GTF3C1 MYH14 SLTM NOL7 EFCC1 SCAF11 PRRC2A CBX8 CKMT1A | 1.52e-05 | 1373 | 145 | 25 | int:MYCN |
| Interaction | KIF20A interactions | NOLC1 ANKRD35 NES AKAP8 ARGLU1 DIDO1 LMNB2 MAP7 PPL SPTBN4 RBM25 INA MYH14 TJP2 MAP7D2 MACF1 ANKRD18A PLEC TET3 ADAMTSL4 PRRC2A | 2.10e-05 | 1052 | 145 | 21 | int:KIF20A |
| Interaction | TRIM27 interactions | NOP53 LENG1 LMNB2 MAP7 PPL ARHGAP22 TFPT KANSL1 RNF6 PIK3C2B NFKBIL1 MAP7D2 LZTS2 CBX8 | 2.12e-05 | 514 | 145 | 14 | int:TRIM27 |
| Interaction | CLIP4 interactions | 2.16e-05 | 47 | 145 | 5 | int:CLIP4 | |
| Interaction | SNRPB interactions | SRSF4 AKAP8 CWC15 DIDO1 ANKZF1 TOE1 SCAF4 NCOA5 RBM25 TCERG1 CCAR1 CC2D2A MACF1 SCAF11 | 2.26e-05 | 517 | 145 | 14 | int:SNRPB |
| Interaction | TCEAL7 interactions | 2.44e-05 | 24 | 145 | 4 | int:TCEAL7 | |
| Interaction | OBSL1 interactions | NOLC1 NES CCDC8 NOP53 TSGA10 LMNB2 SCAF4 NCOA5 MAP7D1 RBM25 INA GTF3C1 CFAP45 SLTM TJP2 MACF1 AFDN PLEC SPEN | 2.61e-05 | 902 | 145 | 19 | int:OBSL1 |
| Interaction | CPSF6 interactions | CCDC8 AKAP8 AKAP17A CWC15 DIDO1 TOE1 SCAF4 NCOA5 RBM25 TCERG1 SLTM CCAR1 SCAF11 CLP1 | 2.74e-05 | 526 | 145 | 14 | int:CPSF6 |
| Interaction | FXR1 interactions | ZNF821 CCDC8 ATN1 AKAP8 DIDO1 ARHGAP22 PHLDB1 INA CCAR1 AFDN JAKMIP1 LZTS2 ADAMTSL4 PRRC2A HOMER3 CBX8 | 3.16e-05 | 679 | 145 | 16 | int:FXR1 |
| Interaction | YWHAE interactions | NOLC1 CCDC8 SRSF4 AKAP8 CDK12 DBNL CDK11A MAP7 MAST2 ANKZF1 CRACD PHLDB1 MAP7D1 INA PIK3C2B TJP2 NHS MACF1 AFDN SCAF11 JAKMIP1 PRRC2A HOMER3 | 3.20e-05 | 1256 | 145 | 23 | int:YWHAE |
| Interaction | DPM2 interactions | 4.28e-05 | 54 | 145 | 5 | int:DPM2 | |
| Interaction | SNRPA interactions | SRSF4 AKAP8 CWC15 DIDO1 MAST2 TOE1 SCAF4 NCOA5 RBM25 TCERG1 SLTM CCAR1 SCAF11 | 4.68e-05 | 482 | 145 | 13 | int:SNRPA |
| Interaction | SHANK3 interactions | ANKRD35 NES ATN1 TRAF3IP1 DBNL DVL1 SPTBN4 PHLDB1 INA MACF1 LZTS2 NUDC HOMER3 | 6.26e-05 | 496 | 145 | 13 | int:SHANK3 |
| Interaction | DGCR6L interactions | 6.95e-05 | 31 | 145 | 4 | int:DGCR6L | |
| Interaction | ARHGEF19 interactions | 7.15e-05 | 60 | 145 | 5 | int:ARHGEF19 | |
| Interaction | PNMA2 interactions | 8.70e-05 | 251 | 145 | 9 | int:PNMA2 | |
| Interaction | TLE3 interactions | ATN1 AKAP8 CDK12 FBRSL1 CBFB SCAF4 SPTBN4 RNF6 CCAR1 NKX2-5 SPEN | 8.96e-05 | 376 | 145 | 11 | int:TLE3 |
| Interaction | MALL interactions | 1.08e-04 | 150 | 145 | 7 | int:MALL | |
| Interaction | CSNK2A1 interactions | NOLC1 CCDC8 ATN1 AKAP8 AKAP17A CDK12 NOP53 ZC3H13 DVL1 FBRSL1 CDK11A HEXIM2 TFPT UTP18 NKX2-5 MACF1 GNL1 CBX8 | 1.79e-04 | 956 | 145 | 18 | int:CSNK2A1 |
| Interaction | NEURL4 interactions | 1.94e-04 | 116 | 145 | 6 | int:NEURL4 | |
| Interaction | DVL3 interactions | 1.98e-04 | 280 | 145 | 9 | int:DVL3 | |
| Interaction | SDHAP2 interactions | 2.30e-04 | 17 | 145 | 3 | int:SDHAP2 | |
| Interaction | WWTR1 interactions | CDK12 DBNL DVL1 DIDO1 RBM25 GTF3C1 TCERG1 AFDN LZTS2 NUDC PRRC2A | 2.45e-04 | 422 | 145 | 11 | int:WWTR1 |
| Interaction | MKI67 interactions | CCDC8 SRSF4 NOP53 LAMB3 ARHGEF18 DIDO1 LMNB2 PHLDB1 MAP7D1 UTP18 GTF3C1 MYH14 SCAF11 SPEN | 2.48e-04 | 648 | 145 | 14 | int:MKI67 |
| Interaction | ATG16L1 interactions | CDK12 CWC15 ZC3H13 DBNL KIF16B DVL1 GMIP PNISR TOE1 RBSN PHLDB1 UTP18 TCERG1 PIK3C2B SLTM CCAR1 PLEC LZTS2 PRRC2A ATG16L2 | 2.50e-04 | 1161 | 145 | 20 | int:ATG16L1 |
| Interaction | HECTD1 interactions | NOLC1 CCDC8 AKAP8 AKAP17A CDK12 NOP53 DIDO1 NCOA5 RBM25 UTP18 GTF3C1 TCERG1 SCAPER MACF1 NOL7 SCAF11 PRRC2A CBX8 | 2.54e-04 | 984 | 145 | 18 | int:HECTD1 |
| Interaction | FOXP3 interactions | AKAP8 NOP53 DBNL CBFB GTF2E1 MAP7D1 GTF3C1 SLTM SCAF11 PLEC PRRC2A | 2.99e-04 | 432 | 145 | 11 | int:FOXP3 |
| Interaction | ZCCHC10 interactions | 3.16e-04 | 236 | 145 | 8 | int:ZCCHC10 | |
| Interaction | CAPN13 interactions | 3.25e-04 | 19 | 145 | 3 | int:CAPN13 | |
| Interaction | YAP1 interactions | ATN1 CDK12 DBNL DIDO1 SCAF4 YOD1 RBM25 INA GTF3C1 TCERG1 MYH14 TJP2 AFDN GNA12 PLEC LZTS2 SPEN NUDC PRRC2A | 3.30e-04 | 1095 | 145 | 19 | int:YAP1 |
| Interaction | HOOK1 interactions | 3.53e-04 | 240 | 145 | 8 | int:HOOK1 | |
| Interaction | SP7 interactions | 3.63e-04 | 304 | 145 | 9 | int:SP7 | |
| Interaction | KCTD13 interactions | NES ARGLU1 DBNL GJC2 MAP7 CCDC177 SPTBN4 CRACD PHLDB1 MAP7D1 INA ARVCF MYH14 SCAPER TJP2 MAP7D2 MACF1 AFDN PLEC BSN PRRC2A HOMER3 | 4.06e-04 | 1394 | 145 | 22 | int:KCTD13 |
| Interaction | SERF2 interactions | 4.14e-04 | 87 | 145 | 5 | int:SERF2 | |
| Interaction | FUOM interactions | 4.41e-04 | 21 | 145 | 3 | int:FUOM | |
| Interaction | DHX40 interactions | 4.51e-04 | 249 | 145 | 8 | int:DHX40 | |
| Interaction | SFN interactions | NOLC1 SRSF4 MAST2 MAP3K6 PHLDB1 MAP7D1 RBM25 INA PIK3C2B CCAR1 TJP2 NHS MACF1 PLEC | 4.80e-04 | 692 | 145 | 14 | int:SFN |
| Interaction | YWHAZ interactions | NOLC1 CCDC8 AKAP8 ARHGEF18 MAP7 MAST2 CRACD PHLDB1 MAP7D1 INA PIK3C2B TJP2 NHS MACF1 AFDN SCAF11 JAKMIP1 PLEC NUDC PRRC2A HOMER3 | 4.96e-04 | 1319 | 145 | 21 | int:YWHAZ |
| Interaction | TOP1 interactions | AKAP8 CWC15 LAMB3 DIDO1 SCAF4 NCOA5 RBM25 GTF3C1 TCERG1 SLTM CCAR1 SCAF11 TNNT1 CBX8 | 5.08e-04 | 696 | 145 | 14 | int:TOP1 |
| Interaction | SNRPB2 interactions | 5.28e-04 | 255 | 145 | 8 | int:SNRPB2 | |
| Interaction | FBXO22 interactions | CWC15 CDK11A TOE1 SCAF4 PHLDB1 MAP7D1 GTF3C1 PIK3C2B CCAR1 TJP2 NUDC CKMT1A | 5.43e-04 | 540 | 145 | 12 | int:FBXO22 |
| Interaction | BARD1 interactions | 5.63e-04 | 323 | 145 | 9 | int:BARD1 | |
| Cytoband | 22q11.21 | 3.27e-05 | 111 | 149 | 5 | 22q11.21 | |
| GeneFamily | EF-hand domain containing|Plakins | 3.96e-08 | 8 | 90 | 4 | 939 | |
| GeneFamily | Intermediate filaments Type IV | 3.63e-04 | 6 | 90 | 2 | 611 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 4.60e-06 | 221 | 147 | 9 | M39222 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | AMER1 ARGLU1 ZC3H13 DIDO1 DDI2 PNISR ZNF711 YOD1 KANSL1 PLEC | 2.13e-05 | 275 | 146 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 4.49e-05 | 186 | 146 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | NES BNC2 AKAP8 FHOD3 MAP7 GALNT16 RBM25 INA PIK3C2B NRK SCAPER GAL3ST3 SLTM CCAR1 MAP7D2 NHS TNNT1 CKMT1A PHACTR1 | 4.56e-05 | 983 | 146 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.22e-07 | 186 | 149 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.94e-07 | 193 | 149 | 8 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-07 | 196 | 149 | 8 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.44e-07 | 197 | 149 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.36e-06 | 178 | 149 | 7 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-06 | 178 | 149 | 7 | 5fc9f41609735b972a2cd0830182d13742cd5bf5 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.63e-06 | 181 | 149 | 7 | faff2a34e391d053a17c926540e6cb46d94dd629 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.63e-06 | 181 | 149 | 7 | 5a9c332c0bf07cc20eaf8cf77b45e73668a6467d | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.63e-06 | 181 | 149 | 7 | 488a517f6e5543b648a2e72e0e04332fad776de6 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.63e-06 | 181 | 149 | 7 | 58651853f9c715075889856793df66ebe00c04f1 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.93e-06 | 184 | 149 | 7 | a6169613c6493b947a176493f542368bfa935dab | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.93e-06 | 184 | 149 | 7 | 51d0447699e3b8f01abbde83f26b748bc9f3c723 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.93e-06 | 184 | 149 | 7 | f7b0bb45a9055ab34e98b251217f6ec38c75ca22 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.93e-06 | 184 | 149 | 7 | cc01c19180861f491a8dc16d60fabd1215fc4525 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.93e-06 | 184 | 149 | 7 | 492c680f0769ba4e651d09c2e8e5d5d271ed08aa | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.93e-06 | 184 | 149 | 7 | 26edbf84216538b80f1ffcc079ee6e385a71fbf9 | |
| ToppCell | Control-Epithelial-Basal/Club|Control / Disease group,lineage and cell class (2021.01.30) | 3.63e-06 | 190 | 149 | 7 | 799b0b1c4bdbe04ee0fc34d0be9e02b5992774a0 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-myofibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.02e-06 | 193 | 149 | 7 | 02dfd1df1e7fc84bfca2b0c95138b5b4408bb5d1 | |
| ToppCell | droplet-Lung-21m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.02e-06 | 193 | 149 | 7 | 3a5ad8ffad441e30a6e1bd017da7720ad57f6c57 | |
| ToppCell | facs-Heart-RA-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 195 | 149 | 7 | 30c75761079fa1e1a3b84d23c88a222f459d5ce5 | |
| ToppCell | (01)_IL1RL1+-(1)_GFP|(01)_IL1RL1+ / shred by cell type by condition | 4.45e-06 | 196 | 149 | 7 | b598b1112242534e139318012b257ed3cb09da83 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.60e-06 | 197 | 149 | 7 | b0fb5774525ba05f60c635d42f14bb8d79bff17c | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.60e-06 | 197 | 149 | 7 | bbb7c106d5b96b8e95aeb3e5c293e104fceea234 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.92e-06 | 199 | 149 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.92e-06 | 199 | 149 | 7 | e19b296d583f8bad3b66ee998a8153634d6fe09e | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.92e-06 | 199 | 149 | 7 | 801887db51ac5dc5b068808ff75e3a46643398e9 | |
| ToppCell | COVID-19_Mild-Neu_2|World / 5 Neutrophil clusters in COVID-19 patients | 7.77e-06 | 140 | 149 | 6 | b1429028c52f84127b894b93b55961badcd5246f | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Tfr.Ctps_(Ctps)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.30e-05 | 90 | 149 | 5 | 4d75217fd6b376bfda3300962cbe4875b31ffdaf | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-05 | 158 | 149 | 6 | 2ae863ccef201414b82a2ecf7cf1bbb1b0ce4a3c | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.42e-05 | 171 | 149 | 6 | e780e63510ca47036bc36ca40ecff4098596ee9e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.75e-05 | 175 | 149 | 6 | 2812ac2ef41d245db544697fb6da1883361c96e8 | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.84e-05 | 176 | 149 | 6 | f3a54038cde58326f1caed96ecca33c141bcc8b3 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.84e-05 | 176 | 149 | 6 | 460cb302c5b3d609c65b924e1d4e8ea057a68485 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.22e-05 | 180 | 149 | 6 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-05 | 182 | 149 | 6 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-05 | 182 | 149 | 6 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.54e-05 | 183 | 149 | 6 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC-HSPC|COVID-19_Severe / Disease group, lineage and cell class | 3.54e-05 | 183 | 149 | 6 | 4146b1c0e5f76d25226745abfa28f77127a444fc | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC|COVID-19_Severe / Disease group, lineage and cell class | 3.54e-05 | 183 | 149 | 6 | 92aab7ce65aca17988bc2add4ff9fb8384e2c21b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.65e-05 | 184 | 149 | 6 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 186 | 149 | 6 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 186 | 149 | 6 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.87e-05 | 186 | 149 | 6 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-05 | 186 | 149 | 6 | 15f2e5905486e33f6f7b3b3e9758a0559e8c61ee | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.99e-05 | 187 | 149 | 6 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.11e-05 | 188 | 149 | 6 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 4.23e-05 | 189 | 149 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.23e-05 | 189 | 149 | 6 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | COVID-19_Severe-HSPC|World / disease group, cell group and cell class | 4.23e-05 | 189 | 149 | 6 | 555c0b13f1508b9e3712b36d77144e73e828bc76 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 189 | 149 | 6 | 1be5067c1e45af7d09c1fd6955952cb9e031a3a0 | |
| ToppCell | COVID-19_Severe-HSPC|COVID-19_Severe / disease group, cell group and cell class | 4.23e-05 | 189 | 149 | 6 | 96015439971e2e5b8d6294ca5a6b873c7774e925 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 189 | 149 | 6 | 30dc1725d43a60017fb12d706f1f85a33de4947e | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 192 | 149 | 6 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 4.62e-05 | 192 | 149 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.62e-05 | 192 | 149 | 6 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 192 | 149 | 6 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 4.62e-05 | 192 | 149 | 6 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 192 | 149 | 6 | f094ac378e635cf5820e8a8b7a0152073a51ceae | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-05 | 192 | 149 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 193 | 149 | 6 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | droplet-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.76e-05 | 193 | 149 | 6 | 25129080f8a40b2988a5d9dfec36ff9e72c27e61 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c4-DNAJB1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.76e-05 | 193 | 149 | 6 | d59c08ee741a1ae478d196c4281ad4ad1f21a8c5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 194 | 149 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.90e-05 | 194 | 149 | 6 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 194 | 149 | 6 | f35f03412b596b6b570b377ba1a607409d984bb1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.90e-05 | 194 | 149 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.04e-05 | 195 | 149 | 6 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-05 | 195 | 149 | 6 | 25703e3c2e0512ef12e7aa389fad3968c3f13905 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-05 | 195 | 149 | 6 | cad21edd90bf3e2fefdf5773a59cb1a664a69ddd | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 5.04e-05 | 195 | 149 | 6 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-05 | 196 | 149 | 6 | b6cc1f466d45479764080d34b1daeb8243a5a9f3 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-05 | 196 | 149 | 6 | ede6104cdfa4ee5287efcca9bbc36677cbf7a8d8 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-05 | 196 | 149 | 6 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-05 | 196 | 149 | 6 | 039044ab28c53391c34d8226fb8cf78549e63ef4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.18e-05 | 196 | 149 | 6 | c57a95f8b4d8d6334f269d3c16246684f4222a3e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.18e-05 | 196 | 149 | 6 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.18e-05 | 196 | 149 | 6 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.18e-05 | 196 | 149 | 6 | 9790340c25f446ec655f5a0b64ec3bb44ed2e1bd | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.18e-05 | 196 | 149 | 6 | b9ceceeacbcf81976ce92adf044f0d0aa132632b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.18e-05 | 196 | 149 | 6 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.18e-05 | 196 | 149 | 6 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-05 | 197 | 149 | 6 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.48e-05 | 198 | 149 | 6 | 1fe60443c11d34b6d2671af8f06e0dedc8d1558b | |
| ToppCell | COVID-19-COVID-19_Severe-Others-HSPC|COVID-19_Severe / Disease, condition lineage and cell class | 5.64e-05 | 199 | 149 | 6 | 25de67b6c9c8d6bb9a538e071a40ef865906c95d | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.64e-05 | 199 | 149 | 6 | 8649c2380285a668782d75eb076ce548eed0911d | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 5.64e-05 | 199 | 149 | 6 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Artery-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.80e-05 | 200 | 149 | 6 | 622206c33640cb2694fe158e8dc55515bb7bd4f5 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Artery|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.80e-05 | 200 | 149 | 6 | 5b4a54cd81bc4d9f5e92798362239e1aa1b70bee | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.80e-05 | 200 | 149 | 6 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Vein|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.80e-05 | 200 | 149 | 6 | b3f93b71589251197cde96b7bc6d065c106f61cd | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.80e-05 | 200 | 149 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Artery|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.80e-05 | 200 | 149 | 6 | 590d1c0f86f136c7e76ea107fbb8ac5ff1164386 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 5.80e-05 | 200 | 149 | 6 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-05 | 200 | 149 | 6 | 4c3c11dd5e71ebc3d62264eeaeb71a850b149779 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.13e-05 | 135 | 149 | 5 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 149 | 149 | 5 | 68661c8facfb638560bb2e2c20d509941286dacb | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-04 | 154 | 149 | 5 | 8dc8f02534c3ebda30bf9e702e36d0c53d89e5a5 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-04 | 155 | 149 | 5 | 216a240bfb82cdefc59e2f342689dbaaacb7c184 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-04 | 155 | 149 | 5 | 59035d792c26d870a8b097939e97fa47859ba68c | |
| ToppCell | BAL-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 1.91e-04 | 158 | 149 | 5 | 73f66689ef59f71b14cb7141ca5951cc47fe57c1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.20e-05 | 50 | 88 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Disease | DiGeorge syndrome (is_implicated_in) | 1.02e-06 | 5 | 139 | 3 | DOID:11198 (is_implicated_in) | |
| Disease | mucin‐16 measurement | 2.20e-05 | 2 | 139 | 2 | EFO_0010609 | |
| Disease | ventral diencephalon volume measurement | 4.56e-04 | 7 | 139 | 2 | EFO_0010337 | |
| Disease | Cleft Palate | 5.92e-04 | 81 | 139 | 4 | C0008925 | |
| Disease | Seizures | 6.03e-04 | 218 | 139 | 6 | C0036572 | |
| Disease | progeria (implicated_via_orthology) | 6.06e-04 | 8 | 139 | 2 | DOID:3911 (implicated_via_orthology) | |
| Disease | kallikrein-11 measurement | 7.76e-04 | 9 | 139 | 2 | EFO_0010573 | |
| Disease | major depressive disorder | 8.56e-04 | 155 | 139 | 5 | MONDO_0002009 | |
| Disease | cancer antigen 125 measurement | 9.67e-04 | 10 | 139 | 2 | EFO_0010603 | |
| Disease | Dental enamel hypoplasia | 1.41e-03 | 12 | 139 | 2 | EFO_1001304 | |
| Disease | Congenital pontocerebellar hypoplasia | 1.66e-03 | 13 | 139 | 2 | C0266468 | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 1.81e-03 | 51 | 139 | 3 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | 2-hydroxyglutarate measurement | 2.53e-03 | 16 | 139 | 2 | EFO_0021506 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 2.86e-03 | 17 | 139 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 2.86e-03 | 17 | 139 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 2.86e-03 | 17 | 139 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 2.86e-03 | 17 | 139 | 2 | C0751780 | |
| Disease | May-White Syndrome | 2.86e-03 | 17 | 139 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 2.86e-03 | 17 | 139 | 2 | C0751781 | |
| Disease | platelet component distribution width | CFAP73 KIF16B SKI SH2D4B ARVCF EXOC3L4 MACF1 GNA12 PLEC PRRC2A | 3.14e-03 | 755 | 139 | 10 | EFO_0007984 |
| Disease | mood instability measurement | 3.20e-03 | 128 | 139 | 4 | EFO_0008475 | |
| Disease | Nuclear non-senile cataract | 3.21e-03 | 18 | 139 | 2 | C1112705 | |
| Disease | Nuclear cataract | 3.21e-03 | 18 | 139 | 2 | C0392557 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 3.21e-03 | 18 | 139 | 2 | C0751779 | |
| Disease | smoking status measurement | NOLC1 SEMA3F BNC2 DRD2 MAST2 GALNT16 SPTBN4 KCNG2 KANSL1 CC2D2A TET3 CBX8 PHACTR1 | 3.37e-03 | 1160 | 139 | 13 | EFO_0006527 |
| Disease | Headache | 3.46e-03 | 64 | 139 | 3 | HP_0002315 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLEAERRARLQDEER | 1596 | P55196 | |
| EEAVRRSAQERVRRP | 246 | Q17RC7 | |
| DRGRRREAARDARAQ | 16 | Q9HCM7 | |
| VEARATRLRDFQERL | 806 | Q6ZSZ5 | |
| ERLREAQRAVERERE | 1121 | Q6ZSZ5 | |
| LDRRENDERRGSDRS | 91 | Q9NYV4 | |
| RAAAERNLRNERRER | 201 | Q8NAA4 | |
| RRFRDLDARDRKDRT | 56 | Q8IVF6 | |
| ARFERLTRALEQERR | 21 | O00192 | |
| ETQEIRAARRSRLRD | 136 | Q6UY14 | |
| RRDRTRDRAADRIQF | 376 | O43823 | |
| VRERETQRDREPKRA | 51 | Q6ZN30 | |
| VPNRKDDRSRERERE | 311 | Q8IX12 | |
| QRLRARCEEESRGRE | 176 | Q16352 | |
| TNTAVSRRERDRERA | 61 | Q9NWB6 | |
| NEDDIRRVLEAARRA | 286 | Q14833 | |
| SDPAAREREREARER | 926 | P54259 | |
| RRFRDLDVRDRKDRT | 56 | A2A2Z9 | |
| REARTREAQAREVRC | 621 | Q5JTC6 | |
| EVGRLREAVAEERRR | 866 | Q8N283 | |
| NRDFRRELEERERAA | 56 | Q9P013 | |
| SEARRNRALRRAAEE | 91 | A6NFT4 | |
| RGQAEVRRRAEEARQ | 276 | Q9HA90 | |
| QRRVREAEESGRRQV | 606 | Q7Z4T9 | |
| RRFRDLDARDRKDRT | 56 | Q9H560 | |
| QRAGRRSEQLREDRT | 41 | Q8N428 | |
| QREALERALARLERR | 1001 | Q96L93 | |
| RFELRGREEARRLEQ | 251 | Q5U651 | |
| DRDRDRERSSDRNKD | 366 | P49756 | |
| RRVREEEIEVDSRVA | 626 | Q14978 | |
| RERELEREREQFRVA | 526 | Q9H1K0 | |
| RRRFAARERQLREEA | 51 | A6NNM3 | |
| ARERQLREEAERERR | 56 | A6NNM3 | |
| LREEAERERRQLADR | 61 | A6NNM3 | |
| RRRFAARERQLREEA | 51 | A6NJZ7 | |
| ARERQLREEAERERR | 56 | A6NJZ7 | |
| LREEAERERRQLADR | 61 | A6NJZ7 | |
| ADEARRRRQFTDVNR | 301 | Q5VVQ6 | |
| LEERRSVAIRSRENV | 91 | Q6IE37 | |
| ERERAKARARPDNER | 216 | Q8TDR0 | |
| QKDRGNRERDRDSER | 231 | Q8TDR0 | |
| RRQARREAEADKPRR | 391 | Q9NZM5 | |
| ELQRERRRGEEQRDS | 581 | Q9BRK4 | |
| EEERAQVRSSVRARR | 311 | P43366 | |
| RREEESRRLEAEQAR | 526 | Q14244 | |
| EARVREEAERVRQER | 571 | Q14244 | |
| SDERQRLAKERREER | 51 | Q96T17 | |
| RLARASEQERRRALR | 101 | Q5T442 | |
| ERRRRSREEAQAKAQ | 251 | Q9P107 | |
| AERLRREAAERSRAE | 201 | Q96BZ8 | |
| FEEEVRETRRRHERR | 226 | Q03252 | |
| RDKEELRAQRRRERS | 1076 | Q9UPA5 | |
| RSLEEARAERERARA | 316 | Q9NSC5 | |
| ARAERERARAEVGRA | 321 | Q9NSC5 | |
| RDRDEFERILRAQRE | 441 | Q9UL16 | |
| RETIRRDIRQARERF | 236 | O95382 | |
| VAAELLDREEARNRR | 51 | Q70Z53 | |
| RRRAAREAEALTQRL | 1411 | Q7Z406 | |
| RRLRRREEEAAEARA | 121 | Q9UJ96 | |
| GEASRVDRLERRERL | 66 | A0A1B0GTQ4 | |
| LERERQARREAEREV | 1406 | O60437 | |
| ARRRTREFEDRDRSH | 146 | Q13951 | |
| DHRDSRSVRDVRDVR | 71 | Q9HCD5 | |
| RSVRDVRDVRDLRDF | 76 | Q9HCD5 | |
| VRDVRDLRDFRDLRD | 81 | Q9HCD5 | |
| ERTARQAREEEARRL | 1546 | Q92817 | |
| QAREEEARRLRERID | 1551 | Q92817 | |
| EARRLRERIDRAETL | 1556 | Q92817 | |
| ARERTTEEVARNRRA | 101 | P48681 | |
| ALLRRQADIESRARR | 286 | Q7Z3B3 | |
| SREIDRARRADIREA | 266 | P49279 | |
| ERDSREEVERRKRAA | 86 | P36915 | |
| AREEARRAFDGERLR | 136 | Q96N16 | |
| RAKEEELRESRARRA | 251 | Q9UBC1 | |
| RETAAAAEEKERRRR | 201 | P31270 | |
| EERRSVAIRSRENVV | 96 | Q6IE36 | |
| EADNAERPRARRRRK | 126 | P52952 | |
| ERAVVRVADERDRVQ | 66 | Q9UPN3 | |
| SAQAEAREEERRVRE | 71 | Q9UMY1 | |
| AREEERRVRETVRRD | 76 | Q9UMY1 | |
| AAAARRRRRVRSEAE | 146 | Q7RTS3 | |
| RSRGEAVAERRREEL | 1436 | O00750 | |
| SEDDIDRRPIRRVRS | 51 | Q9C0D0 | |
| EVERLRARRRELASL | 306 | Q9H3Q3 | |
| CVEREARELREARQR | 316 | Q96A11 | |
| ERERERERERGTSRV | 171 | Q9HC52 | |
| EQEVRERAAQSRRRP | 631 | Q9P2K1 | |
| REREEQRRFAALSDR | 641 | Q9H8Y5 | |
| RQRVRDLEAERARLE | 96 | Q12934 | |
| EREARQRVQSLARRA | 191 | P0CW27 | |
| RERLEAEEERRRLQA | 311 | Q6ZU35 | |
| VEQVARRLTLARRDD | 856 | P12110 | |
| TDADRLRRQERDRVE | 76 | Q5T3F8 | |
| RERDGLEQALRRRES | 191 | Q8N4Y2 | |
| AAERERRRQEREERL | 456 | Q2V2M9 | |
| ESAARRRLAANARER | 36 | Q8N100 | |
| RQREASFIEERRARE | 226 | Q5T5S1 | |
| RERSANRDREREADR | 2151 | Q9BTC0 | |
| DAEREARRRSRDIDA | 31 | Q03113 | |
| RDIDALLARERRAVR | 41 | Q03113 | |
| REHSRRERDRLEQLE | 146 | Q9UQ88 | |
| AEERRKEREARREVS | 186 | Q9UQ88 | |
| ERRRRFVEACRAREA | 176 | Q8N6I1 | |
| REAEARRREEQEARE | 646 | Q3KQU3 | |
| ARSREEAERQRLERE | 681 | Q3KQU3 | |
| RALGTLRQDRAERRE | 1476 | Q6P0Q8 | |
| IARARRLQAEAEEAR | 956 | Q13751 | |
| ERARRRNREEAARTN | 146 | O14640 | |
| RRQRQYERSEERRRE | 416 | Q9NQR7 | |
| YERSEERRRELAERQ | 421 | Q9NQR7 | |
| GLLRRERAERAARED | 436 | Q9NQR7 | |
| NRRRVEAARRAQELE | 266 | P14416 | |
| DRARREQERIRLFSA | 181 | Q5TDH0 | |
| DRARRRNREEAARTN | 146 | P54792 | |
| RNLRVLRAEARAEAE | 516 | Q9H0W5 | |
| RSKRERREEDRAPAE | 231 | Q6NUJ5 | |
| SRSQERRDREKERER | 476 | O95104 | |
| IRTNAEDRARAVIRE | 316 | Q8WWT9 | |
| SRERESDRDGQRRER | 911 | Q99590 | |
| KAREDAARERARDRE | 711 | Q9BY12 | |
| AARERARDREERLAA | 716 | Q9BY12 | |
| EQERRERELREAARR | 206 | Q9UJU6 | |
| RAERREVERVVVDAL | 181 | P12532 | |
| SPEEEERRRVRRERN | 101 | P15407 | |
| ELSDLEARRQRRQRR | 716 | Q7Z2Y5 | |
| DALERAARANLRARR | 96 | A0A3B3IS91 | |
| RRRIETDERDSTNRA | 111 | P29083 | |
| IAVAAAEEERRLRQR | 61 | Q9Y5J1 | |
| RSRSQERRVEEEKRG | 301 | Q08170 | |
| ERIERRRSERAEQQR | 101 | P13805 | |
| RRREIRAEDRFLRTE | 646 | Q13275 | |
| ALRREHRSRSDRREQ | 236 | Q6T4R5 | |
| RRRFAARERQLREEA | 51 | Q9UFD9 | |
| ARERQLREEAERERR | 56 | Q9UFD9 | |
| LREEAERERRQLADR | 61 | Q9UFD9 | |
| RDERQSQRASRVREE | 116 | Q96MH2 | |
| SLAVERARRRREEEE | 461 | P48634 | |
| NELRESDRREVRGER | 836 | Q9NWH9 | |
| SDRREVRGERDERRT | 841 | Q9NWH9 | |
| RTRVFLEQDRERERR | 346 | Q9Y252 | |
| EEEADAERRRRRRGA | 16 | Q8IVW8 | |
| ELARRREERREYLEQ | 81 | A8MXQ7 | |
| APVRREQEAARRLRE | 106 | A8MXQ7 | |
| RRLREQEEAAQRERR | 116 | A8MXQ7 | |
| RQEAERREKAERAAR | 76 | Q9Y266 | |
| REQLRADLLREREAR | 681 | P12755 | |
| LRNSERAREDAERRN | 656 | Q7Z5H3 | |
| RRRLQEAELRRVEEE | 406 | Q02040 | |
| VERSKDFRRECRDER | 286 | Q92989 | |
| AVEQGERALERRRRA | 156 | Q96IU2 | |
| ERALERRRRALQEEE | 161 | Q96IU2 | |
| RRRRALQEEERAAAQ | 166 | Q96IU2 | |
| HERARSRERDLSRDR | 181 | Q9UDY2 | |
| DERIAREEFRRPRES | 2481 | Q8N2C7 | |
| DEEEEAARGRRRRQR | 61 | P0C1Z6 | |
| EREIRRSCEREESLR | 6 | Q96FF7 | |
| SYRQRERERERERFE | 696 | Q96T58 | |
| RQARIEASLRERERE | 861 | O14776 | |
| RRSQYRRSTDREEEE | 1116 | Q5VZP5 | |
| REEARRIRLEQDRDY | 636 | O94804 | |
| REAVQEERQRSRERA | 206 | P48443 | |
| AAARRERRLQEARAL | 761 | Q9H254 | |
| DQSEEAARRRRPERQ | 2256 | Q9H254 | |
| ERLRRLAEDEAFQRR | 2001 | Q15149 | |
| AARQRQLAAEEERRR | 2106 | Q15149 | |
| EERRRREAEERVQKS | 2116 | Q15149 | |
| EEARRLRERAEQESA | 2156 | Q15149 | |
| RREQVERRLQSESAR | 1186 | Q86UU1 | |
| LAERARARQEEAARL | 1716 | O43151 | |
| RDTERRRVFQALARI | 351 | Q6ZUG5 | |
| TERFERERAVQELRR | 636 | Q9BZW7 | |
| RSRLQRDIRREIDDF | 46 | Q7Z3V4 | |
| ETDEQRARRLQRDRE | 311 | O75541 | |
| IRDRRRSNRNSIERE | 591 | Q8TF01 | |
| DEERSRRAQRARDEY | 221 | Q5SQS7 | |
| AERTCEGRRKRDERA | 91 | Q8TDI7 | |
| EGRRKRDERASFQER | 96 | Q8TDI7 | |
| EVDREPSLDRNRRVR | 1196 | Q12789 | |
| RDERRVSRRYEDCQA | 306 | Q9Y462 | |
| RRQEQEEKRRRRESE | 731 | Q07283 | |
| DTDEAAAEDKRRRRR | 326 | Q96GM8 | |
| ARDTRDRRELRDSRD | 461 | Q5T200 | |
| EHDRERERERRDTRQ | 1306 | Q5T200 | |
| SVERDRDRDRDRTFE | 1366 | Q5T200 |